NEW ANTICOAGULATION AND DAPT UPDATE

Sunday, February 26, 2023

5:18 PM – 5:55 PM ET

Moderator(s)

Alexandre A. Abizaid, MD, PhD

Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

Disclosure(s): Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

No relationships to disclose
Dean J. Kereiakes, MD, FACC, MSCAI

President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

Disclosure(s): Elixir Medical: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Orchestra Biomed: Consultant (Ongoing); Shockwave Medical Inc: Consultant (Ongoing); Svelte Medical: Consultant (Ongoing)

Disclosure(s):

Alexandre A. Abizaid, MD, PhD: Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Elixir Medical: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Orchestra Biomed: Consultant (Ongoing); Shockwave Medical Inc: Consultant (Ongoing); Svelte Medical: Consultant (Ongoing)